Craig Packham, PA
Medical · Tooele, UTNPI 1104920354
Payments from drug & device makers
Across 48 payments — averaging $22.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$356
- Smith+Nephew$278
- AbbVie$138
- Boston Scientific$81
- Ferring Pharmaceuticals Inc.$78
- Actelion Pharmaceuticals US, Inc.$26
- plus $103 from 7 others
What the payments were for
- Food & beverage$1,060100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 17 | $356 |
| Smith+Nephew | 9 | $278 |
| AbbVie | 6 | $138 |
| Boston Scientific | 4 | $81 |
| Ferring Pharmaceuticals Inc. | 4 | $78 |
| Actelion Pharmaceuticals US, Inc. | 1 | $26 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $17 |
| Baxter Healthcare | 1 | $16 |
| Bayer | 1 | $16 |
| Hartmann USA, Inc. | 1 | $14 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $14 |
| Vertex | 1 | $14 |
| Heron Therapeutics, Inc. | 1 | $12 |
How this compares
$1,060 in reported general payments places this provider in the 50th percentile of 263 medical providers in Utah.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 25 | $24,494 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 82 | $882 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 88 | $834 |
| Metformin Hcl ErMetformin Hcl | 15 | $768 |
| Gabapentin | 44 | $631 |
| Olmesartan-Amlodipine-HctzOlmesartan/Amlodipin/Hcthiazid | 12 | $509 |
| Celecoxib | 22 | $505 |
| Omeprazole | 30 | $504 |
| Tramadol Hcl | 21 | $339 |
| Tizanidine Hcl | 64 | $315 |
| Ibuprofen | 21 | $314 |
| Atorvastatin Calcium | 36 | $311 |
| Potassium Chloride | 16 | $308 |
| Allopurinol | 28 | $291 |
| Zolpidem Tartrate ErZolpidem Tartrate | 11 | $290 |
Paid to pharmacies, not to this prescriber.
Other medical in Tooele
- Alexandria BurringoTooele$6K
- Elisa WilcoxSalt Lake City$178K
- Viet leSalt Lake City$65K
- Val WarnerLayton$51K
- Carmelo DiazSalt Lake City$35K
- Shari CombeSalt Lake City$22K
- Kelly MikesellOgden$19K
- Jennifer CoombsSlc$12K
- Brandon HansenRiverton$10K
- Daniel CorryCedar City$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.